Siegel DS, Schiller GJ, Song KW, Agajanian R, Stockerl-Goldstein K, Kaya H, Sebag M, Samaras C, Malek E, Talamo G, Seet CS, Mouro J, Pierceall WE, Zafar F, Chung W, Srinivasan S, Agarwal A, Bahlis NJ. Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure. Br J Haematol. 2020 Feb;188(4):501-510. doi: 10.1111/bjh.16213. Epub 2019 Oct 6. PMID: 31588567; PMCID: PMC7027539.

Dolloff NG, Talamo G. Targeted therapy of multiple myeloma. Adv Exp Med Biol. 2013;779:197-221. doi: 10.1007/978-1-4614-6176-0_9. PMID: 23288641.

Talamo G, Sivik J, Pandey MK, Mir MA. Bortezomib-induced acute pancreatitis: Case report and review of the literature. J Oncol Pharm Pract. 2016 Apr;22(2):332-4. doi: 10.1177/1078155214563813. Epub 2014 Dec 15. PMID: 25516544.

The Donald Guthrie Foundation within Guthrie facilitates resident and fellow participation in research projects. Annually, the Donald Guthrie Foundation manages over 200 clinical trials which include sponsored trials from drug and device manufacturers, federally funded clinical trials and investigator-initiated trials. Fellows interested in designing an investigator-initiated research project are also eligible to receive up to $5,000 in grant funding from the Donald Guthrie Foundation to support their research.

All faculty at Guthrie have an active interest in clinical research and have published in major journals. Fellows are encouraged to participate in clinical research programs and to present their results at local and national meetings.